» Articles » PMID: 1436463

Effects of Radiotherapy Determined by 11C-methyl-L-methionine Positron Emission Tomography in Patients with Primary Cerebral Malignant Lymphoma

Overview
Journal Neuroradiology
Specialties Neurology
Radiology
Date 1992 Jan 1
PMID 1436463
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Two cases of histologically proven primary cerebral malignant lymphoma were examined serially with positron emission tomography (PET) using 11C-methyl-L-methionine (11C Met). Lesions delineated by 11C Met accumulation extended beyond enhancing areas on either X-ray computed tomography (CT) or magnetic resonance imaging. High uptake of 11C Met accurately showed biologically active and residual tumours, at a time when disappearance of a contrast-enhancing lesion on CT seemed to indicate involution. PET provides valuable information on the extent of tumour and assessment of radiotherapy in malignant lymphoma.

Citing Articles

PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan.

Kaneta T Jpn J Radiol. 2020; 38(4):343-357.

PMID: 32043236 DOI: 10.1007/s11604-019-00901-8.


Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Challapalli A, Aboagye E Front Oncol. 2016; 6:44.

PMID: 26973812 PMC: 4770188. DOI: 10.3389/fonc.2016.00044.


Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.

Yamane T, Sakamoto S, Senda M Eur J Nucl Med Mol Imaging. 2009; 37(4):685-90.

PMID: 19915838 DOI: 10.1007/s00259-009-1302-y.


Positron emission tomography in patients with primary CNS lymphomas.

Roelcke U, Leenders K J Neurooncol. 1999; 43(3):231-6.

PMID: 10563428 DOI: 10.1023/a:1006202402010.


Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Rigo P, Paulus P, Kaschten B, Hustinx R, Bury T, Jerusalem G Eur J Nucl Med. 1996; 23(12):1641-74.

PMID: 8929320 DOI: 10.1007/BF01249629.


References
1.
Hochberg F, Miller D . Primary central nervous system lymphoma. J Neurosurg. 1988; 68(6):835-53. DOI: 10.3171/jns.1988.68.6.0835. View

2.
Mendenhall N, Thar T, Agee O, Ballinger Jr W, Million R . Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer. 1983; 52(11):1993-2000. DOI: 10.1002/1097-0142(19831201)52:11<1993::aid-cncr2820521104>3.0.co;2-c. View

3.
Kuwabara Y, Ichiya Y, Otsuka M, Miyake Y, Gunasekera R, Hasuo K . High [18F]FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr. 1988; 12(1):47-8. DOI: 10.1097/00004728-198801000-00008. View

4.
Ericson K, Lilja A, Bergstrom M, Collins V, Eriksson L, Ehrin E . Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr. 1985; 9(4):683-9. DOI: 10.1097/00004728-198507010-00005. View

5.
Grant J, Gallagher P, Jones D . Primary cerebral lymphoma. A histologic and immunohistochemical study of six cases. Arch Pathol Lab Med. 1986; 110(10):897-901. View